Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.
Saved in:
| Title: | Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity. |
|---|---|
| Authors: | St-Denis-Bissonnette F; Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Mediratta K; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Ho N; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Kirkby M; Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Stalker A; Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Muradia G; Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Shrestha A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Ardolino M; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Cancer Therapeutics Program, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Lee SH; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Burger D; Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Mer A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; School of Electrical Engineering and Computer Science, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Wang L; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Regenerative Medicine Program, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Lavoie JR; Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, University of Ottawa, Ottawa, ON K1N 6N5, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 Jun 10; Vol. 34 (3), pp. 201261. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
